Physician profile
Jeremy D Fields
NPI 1366577983
$165,116.46
in general payments reported to CMS, 2019-2025
12 companies · $59K in 2025
The $59K reported for 2025 was more than what 98% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,410 · 2020: $6,482 · 2021: $18K · 2022: $32K · 2023: $29K · 2024: $19K · 2025: $59K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $78K · Consulting Fee: $15K · Travel and Lodging: $7,847 · Food and Beverage: $5,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $78,000.00 |
| Consulting Fee | $14,855.09 |
| Travel and Lodging | $7,846.99 |
| Food and Beverage | $5,876.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $129,632.16 | 2019-2025 | Web Aneurysm Embolization System, V-Grip Detachment Controller, Stent |
| Route 92 Medical, INC. | $17,810.46 | 2024-2025 | 8f Base Camp Sheath System |
| Medtronic, INC. | $9,870.75 | 2021-2025 | Solitaire X, Pipeline |
| Stryker Corporation | $5,449.79 | 2019-2025 | Surpass Evolve, Trevo, Target |
| Balt USA, LLC | $1,505.21 | 2019-2022 | |
| Penumbra, INC. | $295.61 | 2022-2025 | Penumbra System, Red 72, Penumbra Coil 400 |
| Medtronic USA, INC. | $269.69 | 2019-2020 | |
| Silk Road Medical, INC. | $152.00 | 2022 | |
| Imperative Care, INC | $51.30 | 2025 | Zoom 88-T Large Distal Platform |
| Edwards Lifesciences Corporation | $48.86 | 2024 | Sapien 3 Ultra Resilia |
| Qapel Medical INC | $15.92 | 2024 | |
| Lemaitre Vascular, INC. | $14.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.